๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fudan University454 Ruijin Hospital276 Shanghai Zhongshan Hospital163 RenJi Hospital135 Children's Hospital of Fudan University84
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Shanghai

3827 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Mi-thosยฎ Transcatheter Mitral Valve Replacement Study
NCT04195984Mitral Valve Regurgitation
Shanghai NewMed Medical Co., Ltd.
Not applicable
122
Beijing, Shanghai, Xiโ€™an
2021-03-25
Active, closed
Camrelizumab Combined With Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma
NCT04521153Hepatocellular Carcinoma, Immunotherapy, Molecular Targeted Therapy
DrugsApatinib Mesylate·Camrelizumab
Shanghai Zhongshan Hospital
Phase 2/3
294
Shanghai
2021-03-25
Recruiting
Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical Trial
NCT05053802Multiple Primary Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
146
Shanghai
2021-03-21
Active, closed
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT04691804Metastatic Castration-Resistant Prostate Cancer (mCRPC)
DrugFluzoparib
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
496
Shanghai, Beijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang
2021-03-18
Recruiting
A Clinical Study to Evaluate Efficacy and Safety of Serplulimab๏ผˆHLX10๏ผ‰ Combined With Bevacizumab๏ผˆHLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC)
NCT04547166Metastatic Colorectal Cancer
DrugsSerplulimab·Bevacizumab
Shanghai Henlius Biotech
Phase 2/3
568
Guangzhou, Hangzhou, Linyi, Shanghai
2021-03-10
Recruiting
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
NCT04686305Locally Advanced or Metastatic Non-Small Cell Lung Cancer
DrugsVolrustomig·Rilvegostomig·Trastuzumab deruxtecan·Durvalumab
AstraZeneca
Phase 1
304
Changchun, Chengdu, Fuzhou, Shandong, Shanghai, Zhengzhou
2021-03-09
Active, closed
Using Left Atrium Appendage Closure in NVAF Patients With High Risk of Ischemic Stroke
NCT04479722Atrial Fibrillation, Stroke
Shanghai MicroPort Medical (Group) Co., Ltd.
Not applicable
210
Shanghai
2021-03-03
Recruiting
Evaluating Omitting of Internal Mammary Irradiation Among Early Stage Intermediate Risk (N1) Breast Cancer
NCT04517266Breast Cancer
Ruijin Hospital
Not applicable
214
Shanghai
2021-03-01
Recruiting
The Effect of Sirolimus on Immunizations During the Treatment of Kaposiform Hemangioendothelioma
NCT05351216Kaposiform Hemangioendothelioma
Children's Hospital of Fudan University
Observational
174
Shanghai
2021-03-01
Recruiting
A Study on Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)
NCT06749015Metastatic Colorectal Cancer, BRAF V600 Mutation
Fudan University
Observational
100
Shanghai
2021-03-01
Recruiting
Neoadjuvant Radiation in Locally Advanced Breast Cancer
NCT05479409Breast Neoplasms
Fudan University
Phase 2
70
Shanghai
2021-03-01
Active, closed
CCCG-ALCL-2020 for Chinese Children and Adolescents With Newly Diagnosed High-risk ALCL
NCT04881838Pediatric Anaplastic Large Cell Lymphoma
Children's Cancer Group, China
Phase 3
172
Shanghai
2021-03-01
Recruiting
Risk Factors for Colonization or Infection With Carbapenem-Resistant Enterobacteriaceae in Children
NCT04535661Carbapenem-Resistant Enterobacteriaceae Infection
Children's Hospital of Fudan University
Observational
536
Shanghai
2021-03-01
Recruiting
A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy
NCT04478292Hepatoblastoma
DrugIrinotecan
Shanghai Children's Medical Center
Phase 3
330
Shanghai
2021-03-01
Not yet open
Early Recurrent Nasopharyngeal Cancer: the Effect of Surgery vs IMRT
NCT04215510Recurrent Nasopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University
Phase 3
286
Fuzhou, Nanchang, Shanghai
2021-03-01
Active, closed
Cohort Study of Airway Microecology and the Pathogenesis and Evolution of Chronic Obstructive Pulmonary Disease
NCT04849104Chronic Obstructive Pulmonary Disease
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Observational
210
Shanghai
2021-02-26
Active, closed
A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
NCT04408638Diffuse Large B-cell Lymphoma
DrugsRituxumab·Glofitamab·Tocilizumab·Obinutuzumab
Hoffmann-La Roche
Phase 3
270
Beijing, Guangzhou, Harbin, Shanghai, Tianjin, Wuhan, Zhejiang, Zhengzhou
2021-02-23
Recruiting
Prospective Cohort Study on the Relationship Between Exosomal Peroxiredoxin 1 (PRDX1) and Postoperative Liver Metastasis
NCT07177742Colorectal Cancer, Liver Metastases From Colorectal Cancer, Pathology, Exosome
Mu-qing Yang
Observational
260
Shanghai
2021-02-15
Recruiting
Impact of Remimazolam on Prognosis After Bladder Cancer Surgery
NCT04532606Benzodiazepines, Bladder Cancer, Delirium, Surgery
DrugsRemimazolam·Propofol
Peking University First Hospital
Phase 4
1,128
Beijing, Beijin, Guiyang, Nanjing, Shanghai
2021-02-05
Active, closed
HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer
NCT04619004Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
DrugPatritumab Deruxtecan
Daiichi Sankyo
Phase 2
277
Beijing, Changchun, Chengdu, Guangzhou, Hangzhou, Harbin, Nanjing, Shanghai
2021-02-02
Recruiting
Alpha-Ketoglutarate and Abdominal Aortic Aneurysm Progression and Rupture
NCT04723888Patients With an Abdominal Aortic Aneurysm of 39-49 mm in Diameter
RenJi Hospital
Not applicable
300
Shanghai
2021-02-01
Recruiting
COVID-2019 Vaccine Immune Response Base on Single Cell Multi-Omics
NCT04871932Immune System and Related Disorders
RenJi Hospital
Observational
50
Shanghai
2021-02-01
Active, closed
A Study of Endovascular Treatment of Femoropopliteal Arterial Occlusive Lesion With Drug-Coated Balloon
NCT04826705Drug-coated Balloon, Femoropopliteal Artery Occlusion, Angioplasty
Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology
Observational
2,000
Wuhan, Beijing, Chengdu, Hangzhou, Qingdao, Shanghai, Suzhou
2021-02-01
Recruiting
Phase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapy
NCT05552846Small-cell Lung Cancer
Ruijin Hospital
Not applicable
104
Shanghai
2021-01-30
Recruiting
Morning Versus Bedtime Dosing of Antihypertensive Medication
NCT05089448Hypertension, Blood Pressure, Drug Use
Yan Li
Phase 4
300
Shanghai
2021-01-28
Active, closed
Intracorporeal Anastomosis Versus Extracorporeal Anastomosis for Left Colon Cancer
NCT04201717Colon Cancer
Jilin University
Not applicable
350
Changchun, Beijing, Chongqing, Guangzhou, Shanghai, Shenyang
2021-01-27
Active, closed
Super Hypofractionated Irradiation for Whole Breast Treatment
NCT04926766Breast Cancer
Ruijin Hospital
Not applicable
217
Shanghai
2021-01-23
Recruiting
Effects of Lifestyle Intervention on Childhood Outcomes in LGA Infants
NCT04661449Childhood Overweight
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
138
Shanghai
2021-01-22
Active, closed
Adjuvant Regional Nodal Radiation Therapy for One Week in Breast Cancer
NCT04509648Breast Cancer
Ruijin Hospital
Not applicable
197
Shanghai
2021-01-21
Active, closed
Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors
NCT04669496Intrahepatic Cholangiocarcinoma, PD1 Antibody, Lenvatinib, Gemox Chemotherapy
Shanghai Zhongshan Hospital
Phase 2/3
178
Shanghai
2021-01-20
Recruiting
Multicenter Study on Laparoscopic Total Gastrectomy for Advanced Gastric Cancer
NCT04710758Stomach Neoplasms
Shanghai Zhongshan Hospital
Not applicable
1,018
Shanghai
2021-01-20
Active, closed
Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
NCT04589845Solid Tumors
DrugsBelvarafenib·Ipatasertib·Pralsetinib·Divarasib
Hoffmann-La Roche
Phase 2
920
Beijing, Chengdu, Shanghai, Tianjin, Xi'an
2021-01-18
Recruiting
Conversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver Metastases
NCT04687631Colorectal Cancer, Liver Metastases
DrugsMFOLFOXIRI·Cetuximab·Bevacizumab
Fudan University
Phase 3
508
Shanghai
2021-01-14
Active, closed
CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Mantle Cell Lymphoma
NCT04718883Mantle Cell Lymphoma
Shanghai Ming Ju Biotechnology Co., Ltd.
Phase 2
59
Beijing, Fuzhou, Guanzhou, Zhengzhou, Nanjing, Shanghai, Tianjin, Hangzhou
2021-01-13
Recruiting
ECMO Treatment of Children in China in the Past 10 Years
NCT04709432Extracorporeal Membrane Oxygenation, Child, Only
Children's Hospital of Fudan University
Observational
500
Shanghai
2021-01-11
Recruiting
Genotype-Phenotype Correlations in Patients With Alport Syndrome
NCT04947813Alport Syndrome
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
8,165
Shanghai
2021-01-01
Active, closed
Robotic Versus Laparoscopic Surgery for Middle and Low Rectal Cancer: a Target Trial Emulation
NCT06814093Rectal Cancer
Xu jianmin
Observational
2,702
Shanghai
2021-01-01
Recruiting
Percutaneous Electrocoagulation Versus Sclerosing Foam for Patients With Incompetent Perforating Veins
NCT04686097Incompetent Perforating Veins
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
84
Hefei, Yantai, Shanghai, Hangzhou
2021-01-01
Recruiting
Postoperative Hypoxemia Increases the Risk of Anastomotic Leak After Radical Esophagectomy
NCT07309991Esophageal Carcinoma, Esophageal Adenocarcinoma, Esophagectomy, PaO2
Sun Yat-sen University
Observational
2,500
Guangzhou, Shantou, Shijiazhuang, Shanghai, Chengdu, Nanchong
2021-01-01
Recruiting
The Association Between Radiation Dermatitis and Skin Microbiome in Breast Cancer Patients
NCT05032768Radiation Dermatitis, Skin Microbiome, Breast Cancer, Reconstructive Surgery
Fudan University
Observational
100
Shanghai
2021-01-01
Recruiting
A Prospective, Two-center, Single Arm Phase II Clinical Study to Evaluate Safety and Effectiveness of Ablation Therapy in the Treatment of Lung Cancer Presenting as Ground-glass Nodules
NCT04905056Progression
Shanghai Zhongshan Hospital
Phase 2
120
Shanghai
2021-01-01
Recruiting
Comparison Of Percutaneous Mechanical Thrombectomy With Different Access in Treatment of Acute Deep Venous Thrombosis
NCT06124768Deep Vein Thrombosis
RenJi Hospital
Observational
210
Shanghai
2021-01-01
Recruiting
Single Arm Phase II Study of Fractionated Stereotatic Radiation Therapy (FSRT) for Bone Metastases in Breast Cancer
NCT04947280Bone Metastases, Breast Cancer
Fudan University
Phase 1/2
120
Shanghai
2021-01-01
Recruiting
Study on Early Genetic Screening and Precise Strategy of Neonatal Critical Illness
NCT04905537Genetic Screening, Hereditary Disease, Newborn, Stillbirth
Children's Hospital of Fudan University
Observational
4,000
Shanghai
2021-01-01
Recruiting
Neuroendocrine Transformation in RB1/TP53 Inactivated NSCLC
NCT06369181Neuroendocrine Carcinoma, Non-small Cell Lung Cancer, Histology Transformation
Fudan University
Observational
50
Shanghai
2021-01-01
Recruiting
Long Term Health Cohort of Premature Infants
NCT05017389Preterm
Shanghai Children's Medical Center
Observational
1,200
Shanghai
2021-01-01
Recruiting
Nomogram for Predicting Difficult Transoral and Submental Thyroidectomy
NCT06671184Differentiated Thyroid Cancer
Shanghai 6th People's Hospital
Observational
500
Shanghai
2021-01-01
By invitation
Strategies for Proactive Health in People With Kidney Function Decline
NCT07245186Renal Insufficiency,Chronic, Dietary Intake Patterns, Malnutrition, Frailty
Huashan Hospital
Observational
1,800
Shanghai
2021-01-01
Active, closed
Optimal Ablation Strategies for Persistent AF With HF
NCT07153718Heart Failure, Persistent Atrial Fibrillation
Xu Liu
Not applicable
300
Anqing, Wuhan, Changshu, Xuzhou, Jinan, Jining, Yuhuan, Shanghai
2021-01-01
Not yet open
Stratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS)
NCT04515602Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
Shanghai Gynecologic Oncology Group
Phase 3
410
Shanghai
2021-01
Recruiting
Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia
NCT04684147Relapsed or Refractory Acute Lymphoblastic Leukemia
DrugSingle of CNCT19
Juventas Cell Therapy Ltd.
Phase 2
100
Beijing, Chongqing, Guangzhou, Sanhe, Zhengzhou, Wuhan, Xuzhou, Shanghai
2020-12-24
Active, closed
A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)
NCT04590235Neurofibromatosis 1, Neurofibroma Plexiform
AstraZeneca
Phase 1
32
Shanghai
2020-12-16
Active, closed
Atrasentan in Patients With IgA Nephropathy
NCT04573478IgA Nephropathy, Immunoglobulin A Nephropathy
DrugsAtrasentan·Zigakibart
Novartis Pharmaceuticals
Phase 3
404
Dongguan, Fuzhou, Baotou, Nanjing, Nantong, Shanghai, Chengdu, รœrรผmqi
2020-12-11
Active, closed
Dacomitinib in Lung Cancer With Uncommon EGFR Mutations
NCT04504071Non-small Cell Lung Cancer Metastatic, EGF-R Positive Non-Small Cell Lung Cancer
DrugDacomitinib
Shanghai Chest Hospital
Phase 2
30
Shanghai
2020-12-08
Recruiting
Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)
NCT04743479Pancreatic Cancer, Diabetes, Familial Pancreatic Cancer, Pancreatic Cystic Neoplasm
Changhai Hospital
Observational
5,000
Shanghai
2020-12-01
Recruiting
Clinical Features and Outcomes of CBP Versus Non-CBP in Septic Children
NCT04794595Sepsis, Children, Only
Children's Hospital of Fudan University
Observational
90
Shanghai
2020-12-01
Recruiting
Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)
NCT07205510Sarcopenia, Metabolic Diseases, All-cause Mortality, Aging
RenJi Hospital
Observational
10,000
Shanghai
2020-12-01
Recruiting
Myocardial Infarction and Periodontitis: Periodontal Health Intervention.
NCT06745141Acute Myocardial Infarction (AMI), Periodontal Disease
Shanghai 10th People's Hospital
Not applicable
100
Shanghai
2020-12-01
Active, closed
Postoperative Thrombosis Prevention in Patients With CD
NCT04486859Cushing Disease, DVT, Pulmonary Embolism
Huashan Hospital
Not applicable
206
Fuzhou, Guangzhou, Wuhan, Shanghai, Chengdu, รœrรผmqi, Beijing
2020-12-01
Recruiting
The Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA)
NCT04858724IgA Nephropathy
Ruijin Hospital
Observational
2,000
Shanghai
2020-12-01
Recruiting
Durg Coated Balloon Angioplasty in Infrapopliteal Lesions
NCT05620095Arteriosclerosis, Peripheral Artery Disease, Chronic Limb Threatening Ischemia
Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology
Observational
1,000
Beijing, Wuhan, Suzhou, Qingdao, Shanghai, Chengdu, Hangzhou
2020-12-01
Recruiting
Cohort Study of Inpatients and Outpatient Patients With Cerebral Small Vessel Disease
NCT05985213Cerebral Small Vessel Diseases
Shanghai Yueyang Integrated Medicine Hospital
Observational
1,078
Shanghai
2020-12-01
Recruiting
Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
NCT05740995Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy
DrugNeoadjuvant anti-PD-1
Shanghai Zhongshan Hospital
Observational
40
Shanghai
2020-12-01
Active, closed
Clinical Cohort Study of DHA in Neurodevelopmental Disorders
NCT05841927Autism or Autistic Traits
Children's Hospital of Fudan University
Not applicable
40
Shanghai
2020-12-01
Active, closed
A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)
NCT04576455Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
DrugsGiredestrant·Fulvestrant
Hoffmann-La Roche
Phase 2
303
Changchun, Guangzhou, Linyi, Nanchang, Shanghai, Tianjin, Wuhan, Xi'an
2020-11-27
Recruiting
Sintilimab Combined With Chidamide in Treating Peripheral T Cell Lymphoma
NCT04512534Peripheral T-cell Lymphoma
Fudan University
Phase 2
51
Shanghai
2020-11-13
Recruiting
Left Atrial Appendage Closure as Secondary Prevention of Atrial Fibrillation-related Embolic Events
NCT04559243Non-valvular Atrial Fibrillation, Embolic Stroke
Lifetech Scientific (Shenzhen) Co., Ltd.
Observational
579
Jinan, Shanghai, Mianyang, Wenzhou
2020-11-12
Active, closed
Effects of Preoperative Enteral Immunonutrition for Esophageal Cancer Patients Given Neoadjuvant Chemoradiotherapy
NCT04513418Esophageal Neoplasms
Hecheng Li M.D., Ph.D
Phase 3
244
Shanghai, Hangzhou, Ningbo
2020-11-10
Active, closed
A Study of SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors
NCT04606472Solid Tumor
DrugSI-B003
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
60
Beijing, Chongqing, Xiamen, Zhengzhou, Wuhan, Shanghai, Chengdu
2020-11-10
Active, closed
Phase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia
NCT04606433Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
47
Hefei, Beijing, Chongqing, Guangzhou, Changsha, Shanghai, Tianjin, Hangzhou
2020-11-04
Active, closed
A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)
NCT04512235AL Amyloidosis
DrugsAnselamimab·Cyclophosphamide, bortezomib, and dexamethasone (CyBorD)
Alexion Pharmaceuticals, Inc.
Phase 3
281
Beijing, Guangzhou, Hangzhou, Shanghai, Suzhou, Wenzhou, Wuhan
2020-11-03
Recruiting
Prospective, Observational Real-world Treatments of AEDH in Large-scale Surgical Cases
NCT04229966Epidural Hematoma, Decompressive Craniectomy, Craniotomy
RenJi Hospital
Observational
2,000
Shanghai
2020-11-02
Active, closed
Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma
NCT04517214Nasopharyngeal Carcinoma
DrugToripalimab
Fudan University
Phase 2
100
Shanghai
2020-11-01
Active, closed
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)
NCT04524871Advanced Liver Cancers
DrugsADG126·Tobemstomig·Tiragolumab·Tocilizumab
Hoffmann-La Roche
Phase 1/2
518
Beijing, Shanghai
2020-11-01
Recruiting
Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT04586478Non-Hodgkin's Lymphoma
DrugSingle of CNCT19
Juventas Cell Therapy Ltd.
Phase 2
60
Beijing, Chongqing, Guangzhou, Zhengzhou, Wuhan, Jinan, Shanghai, Chengdu
2020-10-26
Recruiting
Functional Image-Guided Carbon Ion Irradiation With Simultaneous Integrated Boost for Prostate Cancer
NCT05010343Localized Prostate Cancer
Shanghai Proton and Heavy Ion Center
Phase 2
140
Shanghai
2020-10-15
Active, closed
Myasthenia Gravis Inebilizumab Trial
NCT04524273Myasthenia Gravis
DrugInebilizumab
Amgen
Phase 3
238
Beijing, Guiyang, Hunan, Jinan, Shanghai, Suzhou, Tianjin, Xi'an
2020-10-15
Active, closed
A Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibitors
NCT04434092Paroxysmal Nocturnal Hemoglobinuria
DrugsCrovalimab·Eculizumab
Hoffmann-La Roche
Phase 3
210
Beijing, Guangzhou, Hangzhou, Nanjing, Nantong, Shanghai, Wuhan
2020-10-08
Recruiting
Study of Myasthenic Crisis in China
NCT04837625Myasthenia Gravis, Myasthenic Crisis
Huashan Hospital
Observational
300
Shanghai
2020-10-01
Recruiting
BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction
NCT04528511Atrial Fibrillation New Onset, Acute Myocardial Infarction
Shanghai 10th People's Hospital
Observational
774
Kaifeng, Luoyang, Zhengzhou, Shanghai
2020-10-01
Not yet open
Colorectal Adenoma Canceration in FAP
NCT04531930Familial Adenomatous Polyposis
Changhai Hospital
Observational
124
Shanghai
2020-10-01
Recruiting
Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML
NCT04501120Relapsed/Refractory Acute Myeloid Leukaemia, Myeloid Malignancy
DrugsOlverembatinib·Lisaftoclax·Azacitidine
Ascentage Pharma Group Inc.
Phase 1/2
682
Beijing, Chongqing, Guangzhou, Zhengzhou, Wuhan, Changsha, Suzhou, Shanghai
2020-09-28
Active, closed
A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT
NCT04488822Tenosynovial Giant Cell Tumor
Daiichi Sankyo Co., Ltd.
Phase 3
40
Beijing, Guangzhou, Hangzhou, Shanghai
2020-09-25
Recruiting
Phase Ib Clinical Study of Keynatinib
NCT04807881Lymphoma, B-Cell
Medolution Ltd.
Phase 1
75
Beijing, Shanghai, Chengdu
2020-09-24
Recruiting
Pragmatic Trial of Obsessive-compulsive Disorder
NCT04539951Obsessive-Compulsive Disorder
DrugVenlafaxine
Shanghai Mental Health Center
Phase 2
1,600
Shanghai
2020-09-22
Active, closed
A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
NCT04557098Hematological Malignancies
DrugTeclistamab
Janssen Research & Development, LLC
Phase 2
194
Beijing, Chengdu, Guangzhou, Hangzhou, Shanghai, Shenyang, Tianjin, Xi'an
2020-09-17
Active, closed
Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
NCT04384484Relapsed Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma
DrugsLoncastuximab Tesirine·Rituximab·Oxaliplatin·Gemcitabine
ADC Therapeutics S.A.
Phase 3
440
Beijing, Xiamen, Guangzhou, Zhengzhou, Changchun, Dalian, Shanghai, Chengdu
2020-09-16
Active, closed
PF-07104091 as a Single Agent and in Combination Therapy
NCT04553133Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer
DrugsPF-07104091·Palbociclib·Letrozole·Fulvestrant
Pfizer
Phase 2
157
Shanghai, Tianjin
2020-09-16
Recruiting
Prediction of Neoadjuvant Chemotherapy Efficacy in Locally Advanced Gastric Cancer
NCT05140746Gastric Cancer
Ruijin Hospital
Not applicable
40
Shanghai
2020-09-10
Recruiting
Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B
NCT04896255Chronic Hepatitis b
Huashan Hospital
Observational
33,000
Shanghai
2020-09-09
Recruiting
A Multiple-center Study on the Effect of Different Ways of Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With More Than 50% Solid Components
NCT04581122Progression
Shanghai Zhongshan Hospital
Not applicable
1,500
Shanghai
2020-09-01
Recruiting
Observational Prospective Study of Immune Checkpoint Inhibitors for Solid Neoplasms
NCT04766515Cancer
Fudan University
Observational
6,000
Shanghai
2020-09-01
Recruiting
PD-L1 Antibody (TQB2450) Plus Chemotherapy for Previously Untreated Limited- Stage Small-cell Lung Cancer
NCT04539977Small-cell Lung Cancer
DrugsBenmelstobart·Etoposide·Carboplatin
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
40
Shanghai
2020-09-01
Active, closed
A Clinical Study of the Efficacy of Idebenone in the Treatment of iRBD Into Synucleinopathies
NCT04534023Rapid Eye Movement Sleep Behavior Disorder, Synucleinopathy
DrugIdebenone
Ruijin Hospital
Phase 2
28
Shanghai
2020-08-31
Active, closed
Zanubrutinib, Lenalidomide and Rituximab (ZR2) in Elderly Treatment-naive Patients With Diffuse Large B-cell Lymphoma (DLBCL)
NCT04460248Diffuse Large B Cell Lymphoma
Ruijin Hospital
Phase 2
40
Shanghai
2020-08-26
Recruiting
Total Intravenous Anesthesia and Recurrence Free Survival
NCT04513808Esophageal Cancer
DrugsSevoflurane·Propofol
The Cleveland Clinic
Phase 3
1,614
Shanghai
2020-08-15
Active, closed
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab + Lenalidomide (+Len), and the Safety, Tolerability, and Pharmacokinetics of SC Versus IV Mosunetuzumab + Len in Participants With Follicular Lymphoma
NCT04246086Follicular Lymphoma
DrugsMosunetuzumab·Tocilizumab·Lenalidomide
Hoffmann-La Roche
Phase 1/2
237
Changchun, Chengdu, Shanghai, Tianjing, Xiamen
2020-08-12
Active, closed
PD-1 Antibody (SHR-1210) Plus Capecitabine in Patients with Intrahepatic Cholangiocarcinoma After Surgery
NCT04295317Intrahepatic Cholangiocarcinoma
DrugCapecitabine
Shanghai Zhongshan Hospital
Phase 2
65
Shanghai
2020-08-01
Recruiting
Study on the Efficacy and Timing of ECMO Therapy in Children With Refractory Septic Shock
NCT03948048Septic Shock, Extracorporeal Membrane Oxygenation Complication
Children's Hospital of Fudan University
Observational
60
Shanghai
2020-08-01
Active, closed
Safety and Effectiveness of ENTERPRISE 2 Device in the Endovascular Treatment of Intracranial Aneurysms
NCT04289480Intracranial Aneurysm
Medos International SARL
Observational
164
Beijing, Guangzhou, Zhengzhou, Wuhan, Nanjing, Nanchang, Shenyang, Shanghai
2020-07-30
Rows per page Showing 3501–3600 of 3827
Previous 34 35 36 37 38 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai?page=36

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3,827 of those studies with a site in Shanghai.

How many clinical trials are recruiting in Shanghai?

2,393 of the 3,827 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 737 have not yet opened recruitment, 588 are active but closed to new participants, and 109 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.